Suppr超能文献

冷圈套息肉切除术治疗无黏膜下注射的大型无蒂锯齿状病变的安全性和有效性:一项前瞻性研究。

Safety and Efficacy of Cold Snare Polypectomy Without Submucosal Injection for Large Sessile Serrated Lesions: A Prospective Study.

机构信息

Department of Gastrointestinal Endoscopy, NTT Medical Center Tokyo, Tokyo, Japan.

Division of Gastroenterology, Yokohama Sakae Kyosai Hospital, Yokohama, Japan.

出版信息

Clin Gastroenterol Hepatol. 2022 Feb;20(2):e132-e138. doi: 10.1016/j.cgh.2020.10.053. Epub 2020 Nov 2.

Abstract

BACKGROUND & AIMS: Cold snare polypectomy (CSP) has become the standard resection method for small colorectal polyps (<10 mm). Sessile serrated lesions (SSL) have low prevalence of advanced histology irrespective of size, and thus could be amenable to CSP. In this study, we evaluated the safety and efficacy of CSP for SSLs ≥10 mm.

METHODS

Between November 2018 and January 2020, we prospectively enrolled 300 consecutive patients who underwent CSP for 474 SSLs ≥10 mm. To delineate SSL borders, indigo carmine chromoendoscopy and/or image-enhanced endoscopy was conducted. Piecemeal CSP (pCSP) was performed in cases where en-bloc resection was difficult. Biopsy specimens were obtained from the margins of the post-polypectomy defect to confirm complete resection. Surveillance colonoscopy was performed to screen for local recurrence.

RESULTS

All lesions were successfully resected using CSP without submucosal injection. The median diameter of the resected lesions was 14 mm, and pCSP was used to resect 106 (22%) lesions. Post-polypectomy biopsies revealed residual serrated tissue in only one case (0.2%). Adverse events included immediate bleeding in 8 (3%) patients; no delayed bleeding events occurred, irrespective of the use of antithrombotic drugs. During a 7-month median follow-up period, surveillance colonoscopies were performed for 384 lesions (81%), and no local recurrences were detected.

CONCLUSIONS

CSP without submucosal injection is a safe and effective treatment for SSLs ≥10 mm. UMIN Clinical Trials, Number: UMIN000034763.

摘要

背景与目的

冷圈套息肉切除术(CSP)已成为切除小的结直肠息肉(<10mm)的标准方法。无蒂锯齿状病变(SSL)的高级别组织学发生率与其大小无关,因此可能适合采用 CSP 进行治疗。本研究旨在评估 CSP 治疗直径≥10mm 的 SSL 的安全性和有效性。

方法

2018 年 11 月至 2020 年 1 月,我们前瞻性地纳入了 300 例连续接受 CSP 治疗的直径≥10mm 的 474 个 SSL 患者。为了描绘 SSL 边界,我们进行了靛胭脂染色 chromoendoscopy 和/或增强内镜检查。对于难以整块切除的病例,我们采用分片 CSP(pCSP)。从息肉切除后的缺损边缘获取活检标本以确认完全切除。进行监测性结肠镜检查以筛查局部复发。

结果

所有病变均成功地使用 CSP 切除,而无需黏膜下注射。切除病变的中位直径为 14mm,106 个(22%)病变采用 pCSP 切除。息肉切除后的活检仅发现 1 例(0.2%)有锯齿状组织残留。不良事件包括 8 例(3%)患者的即刻出血;无论是否使用抗血栓药物,均未发生迟发性出血事件。在中位 7 个月的随访期间,对 384 个病变(81%)进行了监测性结肠镜检查,未发现局部复发。

结论

不进行黏膜下注射的 CSP 是治疗直径≥10mm 的 SSL 的一种安全有效的方法。UMIN 临床试验,编号:UMIN000034763。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验